학술논문
Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study
Document Type
Article
Author
Source
In JTO Clinical and Research Reports December 2023 4(12)
Subject
Language
ISSN
2666-3643